Their are lot of updates in HCPCS codes in october 2019. Again their will be many C codes will be deleted and will be replaced with new HCPCS codes from 1st October 2019.

This October 2019 Update of the Hospital Outpatient Prospective Payment System (OPPS) or the October 2019 Update of the Ambulatory Surgical Center (ASC) Payment System change request (CR) document for payment and other information related to these HCPCS C-code(s) is now confirmed by CMS as well.

Deleted List of C codes from October 2019

C9035 Injection, aripiprazole lauroxil (aristada initio), 1 mg

C9036 Injection, patisiran, 0.1 mg

C9037 Injection, risperidone (perseris), 0.5 mg

C9038 Injection, mogamulizumab-kpkc, 1 mg

C9039 Injection, plazomicin, 5 mg

C9040 Injection, fremanezumab-vfrm, 1mg

C9043 Injection, levoleucovorin, 1 mg

C9044 Injection, cemiplimab-rwlc, 1 mg

C9045 Injection, moxetumomab pasudotox-tdfk, 0.01 mg

C9048 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg

C9049 Injection, tagraxofusp-erzs, 10 mcg

C9050 Injection, emapalumab-lzsg, 1 mg

C9051 Injection, omadacycline, 1 mg

C9052 Injection, ravulizumab-cwvz, 10 mg

C9447 Injection, phenylephrine and ketorolac, 4 ml vial

List of Replaced codes effective from October 2019

C9035 will be deleted September 30, 2019 and replaced with J1943 (Injection, aripiprazole lauroxil, (aristada initio), 1 mg) effective October 1, 2019.

C9036 will be deleted September 30, 2019 and replaced with J0222 (Injection, patisiran, 0.1 mg) effective October 1, 2019.

C9037 will be deleted September 30, 2019 and replaced with J2798 (Injection, risperidone, (perseris), 0.5 mg) effective October 1, 2019.

C9038 will be deleted September 30, 2019 and replaced with J9204 (Injection, mogamulizumab-kpkc, 1 mg) effective October 1, 2019.

C9039 will be deleted September 30, 2019 and replaced with J0291 (Injection, plazomicin, 5 mg) effective October 1, 2019.

C9040 will be deleted September 30, 2019 and replaced with J3031 (Injection, fremanezumab-vfrm, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)) effective October 1, 2019.

C9043 will be deleted September 30, 2019 and replaced with J0641 (Injection, levoleucovorin, 0.5 mg) effective October 1, 2019.

C9044 will be deleted September 30, 2019 and replaced with J9119 (Injection, cemiplimab-rwlc, 1 mg) effective October 1, 2019.

C9045 will be deleted September 30, 2019 and replaced with J9313 (Injection, moxetumomab pasudotox-tdfk, 0.01 mg) effective October 1, 2019.

C9048 will be deleted September 30, 2019 and replaced with J1096 (Dexamethasone, lacrimal ophthalmic insert, 0.1 mg) effective October 1, 2019.

C9049 will be deleted September 30, 2019 and replaced with J9269 (Injection, tagraxofusp-erzs, 10 micrograms) effective October 1, 2019.

C9050 will be deleted September 30, 2019 and replaced with J9210 (Injection, emapalumab-lzsg, 1 mg) effective October 1, 2019.

C9051 will be deleted September 30, 2019 and replaced with J0121 (Injection, omadacycline, 1 mg) effective October 1, 2019.

C9052 will be deleted September 30, 2019 and replaced with J1303 (Injection, ravulizumab-cwvz, 10 mg) effective October 1, 2019.

C9447 will be deleted September 30, 2019 and replaced with J1097 (Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml) effective October 1, 2019.

References:

https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.html